SNY - FDA evaluating reports of GLP-1 drugs and negative side effects
2024-01-05 14:31:55 ET
More on AstraZeneca, Eli Lilly, etc.
- Profiting From Obesity Drugs HRTS, Novo Nordisk And Eli Lilly
- Why AstraZeneca's Gracell Biotechnologies Acquisition Is A Win-Win
- Eli Lilly: Consider Cutting Before The Southbound Train Leaves (Rating Downgrade)
- Study finds Wegovy not associated with suicidal thoughts in users
- Florida wins FDA nod for mass drug imports from Canada (update)
For further details see:
FDA evaluating reports of GLP-1 drugs and negative side effects